FDA
label_change
· 2015-08-07
FDA Approved: IMODIUM MULTI-SYMPTOM RELIEF — Supplemental Application (Kenvue Brands LLC)
Summary
FDA approved a supplemental submission to add Imodium Multi-Symptom Relief (loperamide hydrochloride and dimethicone) to its product line under Kenvue Brands LL…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IMODIUM MULTI-SYMPTOM RELIEF (LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE)